• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ProMIS Neurosciences Inc. - Common Shares (NQ:PMN)

    0.5500 -0.0196 (-3.44%)
    Streaming Delayed Price Updated: 10:07 AM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 376,398
    Open 0.5540
    Bid (Size) 0.5401 (18)
    Ask (Size) 0.5518 (5)
    Prev. Close 0.5696
    Today's Range 0.5318 - 0.5663
    52wk Range 0.3800 - 1.590
    Shares Outstanding 32,689,190
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's After-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga

    Performance

    YTD
    -42.7%
    -42.7%
    1 Month
    +25.9%
    +25.9%
    3 Month
    +40.3%
    +40.3%
    6 Month
    -2.9%
    -2.9%
    1 Year
    -46.6%
    -46.6%

    More News

    Read More
    ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
    Via Benzinga
    ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    What's going on in today's pre-market session
    Via Chartmill
    ProMIS Neurosciences Announces Private Placement Financing
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Which stocks are experiencing notable movement on Tuesday?
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session.
    Via Chartmill
    Gapping stocks in Tuesday's session
    Via Chartmill
    Which stocks are moving before the opening bell on Tuesday?
    Via Chartmill
    ProMIS Neurosciences Announces Private Placement Financing
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    Which stocks are experiencing notable movement on Monday?
    Via Chartmill
    Monday's session: most active stocks
    Via Chartmill
    These stocks have an unusual volume in today's session
    Via Chartmill
    Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results
    Via Benzinga
    Dow Gains 50 Points; Verizon Earnings Top Views
    Via Benzinga
    Topics Stocks
    Get insights into the top gainers and losers of Monday's pre-market session.
    Via Chartmill
    ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson (NYSE: MCK) Sends “FOCUSfactor” Exploding Across North America – More Stocks Inside
    Via AB Newswire
    Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is ProMIS Neurosciences Inc. - Common Shares publicly traded?
    Yes, ProMIS Neurosciences Inc. - Common Shares is publicly traded.
    What exchange does ProMIS Neurosciences Inc. - Common Shares trade on?
    ProMIS Neurosciences Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for ProMIS Neurosciences Inc. - Common Shares?
    The ticker symbol for ProMIS Neurosciences Inc. - Common Shares is PMN on the Nasdaq Stock Market
    What is the current price of ProMIS Neurosciences Inc. - Common Shares?
    The current price of ProMIS Neurosciences Inc. - Common Shares is 0.5500
    When was ProMIS Neurosciences Inc. - Common Shares last traded?
    The last trade of ProMIS Neurosciences Inc. - Common Shares was at 10/09/25 10:07 AM ET
    What is the market capitalization of ProMIS Neurosciences Inc. - Common Shares?
    The market capitalization of ProMIS Neurosciences Inc. - Common Shares is 17.98M
    How many shares of ProMIS Neurosciences Inc. - Common Shares are outstanding?
    ProMIS Neurosciences Inc. - Common Shares has 18M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.